Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-10-21

FDA Approved: PALONOSETRON HYDROCHLORIDE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for palonosetron hydrochloride by Sandoz Inc under ANDA 202521. The approval confirms the generic product for its approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

SUPPL AP for PALONOSETRON HYDROCHLORIDE (PALONOSETRON HYDROCHLORIDE)